|
Chon, J K; Borkowski, A; Partin, A W et al. (1999) Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia. J Urol 161:2002-8
|
|
Crone, J K; Burnett, A L; Chamness, S L et al. (1998) Neuronal nitric oxide synthase in the canine prostate: aging, sex steroid, and pathology correlations. J Androl 19:358-64
|
|
Barrack, E R (1997) TGF beta in prostate cancer: a growth inhibitor that can enhance tumorigenicity. Prostate 31:61-70
|
|
Jarrard, D F; Paul, R; van Bokhoven, A et al. (1997) P-Cadherin is a basal cell-specific epithelial marker that is not expressed in prostate cancer. Clin Cancer Res 3:2121-8
|
|
Morton Jr, R A; Watkins, J J; Bova, G S et al. (1996) Hypermethylation of chromosome 17P locus D17S5 in human prostate tissue. J Urol 156:512-6
|
|
Epner, D E; Coffey, D S (1996) There are multiple forms of glyceraldehyde-3-phosphate dehydrogenase in prostate cancer cells and normal prostate tissue. Prostate 28:372-8
|
|
McEntee, M F; Epstein, J I; Syring, R et al. (1996) Characterization of prostatic basal cell hyperplasia and neoplasia in aged macaques: comparative pathology in human and nonhuman primates. Prostate 29:51-9
|
|
Sommerfeld, H J; Meeker, A K; Piatyszek, M A et al. (1996) Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res 56:218-22
|
|
Burnett, A L; Saito, S; Maguire, M P et al. (1995) Localization of nitric oxide synthase in spinal nuclei innervating pelvic ganglia. J Urol 153:212-7
|
|
Chamness, S L; Ricker, D D; Crone, J K et al. (1995) The effect of androgen on nitric oxide synthase in the male reproductive tract of the rat. Fertil Steril 63:1101-7
|
Showing the most recent 10 out of 23 publications
